Replies to post #11604 on Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

“I suggest that the only issue in doubt is a label that incorporates the dosing regime.”

Totally agree. And the market does not like this decision. I expect the prudent call will be to wait for the outcome and then invest. There still will be upside after the ruling